PUBLISHER: Grand View Research | PRODUCT CODE: 2152311
PUBLISHER: Grand View Research | PRODUCT CODE: 2152311
The global artificial heart market size was estimated at USD 3.5 billion in 2025 and is projected to grow from USD 3.8 billion in 2026 to USD 8.1 billion by 2033, growing at a CAGR of 11.3% from 2026 to 2033. The North America dominated the market, accounting for a revenue share of 64.0% in 2025. Some of the key factors driving the market are the rising prevalence of heart failure and other cardiac disorders, the shortage of donor organs for heart transplantation, and recent developments in medicine.
According to an article published by the British Society of Echocardiography in February 2025, nearly 7.6 million people were suffering from heart or circulatory disease in the UK, and more than a million people were living with the risk of heart failure. With the global population aging, there is a growing need for cardiac care and devices such as artificial hearts.
Increased knowledge among patients and healthcare professionals about the benefits of an artificial heart in extending and enhancing quality of life is driving market acceptance. Furthermore, the availability of advanced artificial heart implants in certain regions at lower costs than traditional transplantation is another key factor driving medical tourism for cardiac treatment. For instance, according to an article published by the India Cardiac Surgery Site, the average cost of a ventricular assist device or artificial heart transplant in India was estimated at around USD 54,000 to USD 98,000.
Technological breakthroughs in materials science, robotics, and biotechnology have led to the creation of more advanced heart devices, driving market expansion. The development of fully implantable artificial hearts, such as the SynCardia Total Artificial Heart, which provides circulatory support for patients with end-stage biventricular heart failure, represents a significant innovation in the industry. These devices offer patients a longer-term solution than temporary assist devices, showcasing the ongoing advancement in artificial heart technology. Collaboration among research centers, medical device manufacturers, and academic institutions is driving the development of more innovative artificial heart technologies.
The ongoing shortage of donor organs for heart transplantation has created an unmet need for patients with end-stage heart failure, making the artificial heart a practical alternative. According to Oxford University Press, over 64 million people worldwide suffer from heart failure, with only 6,000 receiving a donor heart. This scarcity necessitates the development and use of an artificial heart to sustain patients while they wait for a suitable donor organ. According to the U.S. Health Resources & Services Administration and the Organ Procurement and Transplantation Network, around 3,436 patients are waiting for transplants.
Global Artificial Heart Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global artificial heart market report based on type, therapy, and region:
LVADs
Heart-lung Machine
Total Artificial Heart
Bridge to Transplant
Destination Therapy
Bridge to Decision
Others
North America
Europe
Asia Pacific
Latin America
Middle East and Africa (MEA)